Search Results - "Dowdy, D W"

Data needs for evidence-based decisions: a tuberculosis modeler's 'wish list' [Review article] by Dowdy, D. W., Dye, C., Cohen, T.

“…Infectious disease models are important tools for understanding epidemiology and supporting policy decisions for disease control. In the case of tuberculosis…”
Get full text

Reply to Anthony et al., "Protecting Pyrazinamide, a Priority for Improving Outcomes in Multidrug-Resistant Tuberculosis Treatment" by Fofana, M O, Dowdy, D W

Get full text

Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia by Putri, F. A., Burhan, E., Nawas, A., Soepandi, P. Z., Sutoyo, D. K., Agustin, H., Isbaniah, F., Dowdy, D. W.

“…SETTING:Programmatic management of drug-resistant tuberculosis at Persahabatan Hospital, Jakarta, Indonesia. OBJECTIVE:To evaluate the association between body…”
Get full text

Screening for active tuberculosis: methodological challenges in implementation and evaluation [State of the art series. Active case finding/screening. Number 4 in the series] by Golub, J. E., Dowdy, D. W.

“…As active screening strategies for tuberculosis (TB) continue to rise globally, it has become increasingly important to consider the methodological challenges…”
Get full text

Modelling the social and structural determinants of tuberculosis: opportunities and challenges by Pedrazzoli, D., Boccia, D., Dodd, P. J., Lönnroth, K., Dowdy, D. W., Siroka, A., Kimerling, M. E., White, R. G., Houben, R. M. G. J.

“…INTRODUCTION: Despite the close link between tuberculosis (TB) and poverty, most mathematical models of TB have not addressed underlying social and structural…”
Get full text

Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis by Gomez, G B, Dowdy, D W, Bastos, M L, Zwerling, A, Sweeney, S, Foster, N, Trajman, A, Islam, M A, Kapiga, S, Sinanovic, E, Knight, G M, White, R G, Wells, W A, Cobelens, F G, Vassall, A

“…Despite improvements in treatment success rates for tuberculosis (TB), current six-month regimen duration remains a challenge for many National TB Programmes,…”
Get full text

Screening for TB using chest radiography: remembering the past in order to repeat it by Dowdy, D. W.

Get full text

Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults by Sun, D., Dorman, S., Shah, M., Manabe, Y. C., Moodley, V. M., Nicol, M. P., Dowdy, D. W.

“…SETTING: In-patient hospitals in South Africa and Uganda.OBJECTIVE: To evaluate the cost-effectiveness of a lateral-flow urine lipoarabinomannan (LAM) test…”
Get full text

Cost-effectiveness of rapid susceptibility testing against second-line drugs for tuberculosis by Dowdy, D. W., Hoog, A. van't, Shah, M., Cobelens, F.

“…BACKGROUND:Drug susceptibility testing (DST) against second-line tuberculosis drugs (SLDs) is essential for improving outcomes among multidrug-resistant (MDR-)…”
Get full text

Cost-effectiveness of novel first-line treatment regimens for tuberculosis by Owens, J. P., Fofana, M. O., Dowdy, D. W.

“…OBJECTIVE: To evaluate the cost-effectiveness of novel first-line treatment regimens for tuberculosis (TB).DESIGN: Using decision analysis, we projected the…”
Get full text

Cost-effectiveness of tuberculosis screening and isoniazid treatment in the TB/HIV in Rio (THRio) Study by Azadi, M., Bishai, D. M., Dowdy, D. W., Moulton, L. H., Cavalcante, S., Saraceni, V., Pacheco, A. G., Cohn, S., Chaisson, R. E., Durovni, B., Golub, J. E.

“…OBJECTIVE: To estimate the incremental cost-effectiveness of tuberculosis (TB) screening and isoniazid preventive therapy (IPT) among human immunodeficiency…”
Get full text

Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis by Dowdy, D W, O'Brien, M A, Bishai, D

“…SETTING: The potential cost-effectiveness of improved diagnostic tests for tuberculosis (TB) in resource-limited settings is unknown.OBJECTIVE: To estimate the…”
Get full text

Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling by Dowdy, D. W., Houben, R., Cohen, T., Pai, M., Cobelens, F., Vassall, A., Menzies, N. A., Gomez, G. B., Langley, I., Squire, S. B., White, R., for the TB MAC meeting participants

“…The landscape of diagnostic testing for tuberculosis (TB) is changing rapidly, and stakeholders need urgent guidance on how to develop, deploy and optimize TB…”
Get full text

How can mathematical models advance tuberculosis control in high HIV prevalence settings? by Houben, R. M. G. J., Dowdy, D. W., Vassall, A., Cohen, T., Nicol, M. P., Granich, R. M., Shea, J. E., Eckhoff, P., Dye, C., Kimerling, M. E., White, R. G., for the TB MAC TB-HIV meeting participants

“…Existing approaches to tuberculosis (TB) control have been no more than partially successful in areas with high human immunodeficiency virus (HIV) prevalence…”
Get full text

The urgent need to improve clinical practice guidelines for pediatric tuberculosis by Dowdy, D. W.

Get full text

Xpert at 8 years: where are we now, and what should we do next? by Dowdy, D. W.

Get full text

Implementation of Xpert® MTB/RIF: real challenges, real promise by Dowdy, D. W.

Get full text

Quality of life among people treated for tuberculosis and human immunodeficiency virus in Rio de Janeiro, Brazil [Short communication] by Dowdy, D. W., Israel, G., Vellozo, V., Saraceni, V., Cohn, S., Cavalcante, S., Chaisson, R. E., Golub, J. E., Durovni, B.

“…We measured quality of life (QOL) among individuals receiving treatment for human immunodeficiency virus (HIV; n = 45), active tuberculosis (TB; n = 44) and…”
Get full text

Considering equity in priority setting using transmission models: Recommendations and data needs by Quaife, M., Medley, GF, Jit, M., Drake, T., Asaria, M., van Baal, P., Baltussen, R., Bollinger, L., Bozzani, F., Brady, O., Broekhuizen, H., Chalkidou, K., Chi, Y.-L., Dowdy, DW, Griffin, S., Haghparast-Bidgoli, H., Hallett, T., Hauck, K., Hollingsworth, TD, McQuaid, CF, Menzies, NA, Merritt, MW, Mirelman, A., Morton, A., Ruiz, FJ, Siapka, M., Skordis, J., Tediosi, F., Walker, P., White, RG, Winskill, P., Vassall, A., Gomez, GB

“…Disease transmission models are used in impact assessment and economic evaluations of infectious disease prevention and treatment strategies, prominently so in…”
Get full text

Finding TB´s "missing millions", one district at a time by Dowdy, D. W., Islam, M. Akramul

Get full text